Stockreport

Viatris Inc. (VTRS) FDA Accepts sNDA for Presbyopia Treatment with October PDUFA Date [Yahoo! Finance]

Viatris Inc.  (VTRS) 
PDF Viatris Inc. (NASDAQ: VTRS ) is one of the most undervalued stocks under $30 to buy . On February 25, Viatris announced that the FDA accepted its sNDA for MR-141, which [Read more]